Clinical impact of patients with ruptured esophageal varices with death outcome

Tadahiro Nozoe, Takashi Matsumata, Keizo Sugimachi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background/Aims: High hemostasis rates for ruptured esophageal varices have been acquired, but many patients die of liver failure afterwards. The aim of the current study is to find clinical information about the patients with ruptured esophageal varices who died during an early period after acquiring a hemostasis. Methodology: Forty-five patients with ruptured esophageal varices, including 17 who died during two months after acquiring a hemostasis by an initial endoscopic therapy, were investigated in the current study. The relationship between the clinical data and the prognosis of the patients were examined. Results: The proportion of cases with Child-Pugh C in patients who died after therapy significantly higher than that in survivors (P<0.01). The level of hemoglobin in patients who died was significantly lower than that in the survivors (P<0.01). Moreover the proportion of an elevation of serum C-reactive protein in patients who died was significantly higher than that of the survivors (P<0.05). Conclusions: Our investigation suggested that the elevation of serum C-reactive protein level and a devastated liver function influenced by hemorrhage may be indicators of unfavorable outcomes of the patients with ruptured esophageal varices.

Original languageEnglish
Pages (from-to)185-187
Number of pages3
JournalHepato-gastroenterology
Volume49
Issue number43
Publication statusPublished - Apr 18 2002

Fingerprint

Esophageal and Gastric Varices
Survivors
Hemostasis
C-Reactive Protein
Blood Proteins
Endoscopic Hemostasis
Liver Failure
Hemoglobins
Hemorrhage
Liver
Therapeutics

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

Nozoe, T., Matsumata, T., & Sugimachi, K. (2002). Clinical impact of patients with ruptured esophageal varices with death outcome. Hepato-gastroenterology, 49(43), 185-187.

Clinical impact of patients with ruptured esophageal varices with death outcome. / Nozoe, Tadahiro; Matsumata, Takashi; Sugimachi, Keizo.

In: Hepato-gastroenterology, Vol. 49, No. 43, 18.04.2002, p. 185-187.

Research output: Contribution to journalArticle

Nozoe, T, Matsumata, T & Sugimachi, K 2002, 'Clinical impact of patients with ruptured esophageal varices with death outcome', Hepato-gastroenterology, vol. 49, no. 43, pp. 185-187.
Nozoe, Tadahiro ; Matsumata, Takashi ; Sugimachi, Keizo. / Clinical impact of patients with ruptured esophageal varices with death outcome. In: Hepato-gastroenterology. 2002 ; Vol. 49, No. 43. pp. 185-187.
@article{8795f5b60f6349b9a2dfa2928076a3c9,
title = "Clinical impact of patients with ruptured esophageal varices with death outcome",
abstract = "Background/Aims: High hemostasis rates for ruptured esophageal varices have been acquired, but many patients die of liver failure afterwards. The aim of the current study is to find clinical information about the patients with ruptured esophageal varices who died during an early period after acquiring a hemostasis. Methodology: Forty-five patients with ruptured esophageal varices, including 17 who died during two months after acquiring a hemostasis by an initial endoscopic therapy, were investigated in the current study. The relationship between the clinical data and the prognosis of the patients were examined. Results: The proportion of cases with Child-Pugh C in patients who died after therapy significantly higher than that in survivors (P<0.01). The level of hemoglobin in patients who died was significantly lower than that in the survivors (P<0.01). Moreover the proportion of an elevation of serum C-reactive protein in patients who died was significantly higher than that of the survivors (P<0.05). Conclusions: Our investigation suggested that the elevation of serum C-reactive protein level and a devastated liver function influenced by hemorrhage may be indicators of unfavorable outcomes of the patients with ruptured esophageal varices.",
author = "Tadahiro Nozoe and Takashi Matsumata and Keizo Sugimachi",
year = "2002",
month = "4",
day = "18",
language = "English",
volume = "49",
pages = "185--187",
journal = "Acta hepato-splenologica",
issn = "0172-6390",
publisher = "H.G.E. Update Medical Publishing Ltd.",
number = "43",

}

TY - JOUR

T1 - Clinical impact of patients with ruptured esophageal varices with death outcome

AU - Nozoe, Tadahiro

AU - Matsumata, Takashi

AU - Sugimachi, Keizo

PY - 2002/4/18

Y1 - 2002/4/18

N2 - Background/Aims: High hemostasis rates for ruptured esophageal varices have been acquired, but many patients die of liver failure afterwards. The aim of the current study is to find clinical information about the patients with ruptured esophageal varices who died during an early period after acquiring a hemostasis. Methodology: Forty-five patients with ruptured esophageal varices, including 17 who died during two months after acquiring a hemostasis by an initial endoscopic therapy, were investigated in the current study. The relationship between the clinical data and the prognosis of the patients were examined. Results: The proportion of cases with Child-Pugh C in patients who died after therapy significantly higher than that in survivors (P<0.01). The level of hemoglobin in patients who died was significantly lower than that in the survivors (P<0.01). Moreover the proportion of an elevation of serum C-reactive protein in patients who died was significantly higher than that of the survivors (P<0.05). Conclusions: Our investigation suggested that the elevation of serum C-reactive protein level and a devastated liver function influenced by hemorrhage may be indicators of unfavorable outcomes of the patients with ruptured esophageal varices.

AB - Background/Aims: High hemostasis rates for ruptured esophageal varices have been acquired, but many patients die of liver failure afterwards. The aim of the current study is to find clinical information about the patients with ruptured esophageal varices who died during an early period after acquiring a hemostasis. Methodology: Forty-five patients with ruptured esophageal varices, including 17 who died during two months after acquiring a hemostasis by an initial endoscopic therapy, were investigated in the current study. The relationship between the clinical data and the prognosis of the patients were examined. Results: The proportion of cases with Child-Pugh C in patients who died after therapy significantly higher than that in survivors (P<0.01). The level of hemoglobin in patients who died was significantly lower than that in the survivors (P<0.01). Moreover the proportion of an elevation of serum C-reactive protein in patients who died was significantly higher than that of the survivors (P<0.05). Conclusions: Our investigation suggested that the elevation of serum C-reactive protein level and a devastated liver function influenced by hemorrhage may be indicators of unfavorable outcomes of the patients with ruptured esophageal varices.

UR - http://www.scopus.com/inward/record.url?scp=0036213988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036213988&partnerID=8YFLogxK

M3 - Article

C2 - 11941949

AN - SCOPUS:0036213988

VL - 49

SP - 185

EP - 187

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

SN - 0172-6390

IS - 43

ER -